1. Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer

Volume 22, Issue 8, August 2021, Pages 2569-2576

Anurag Mehta; Anuj Parkash; Meenu Bhatia

• View Article
• PDF 396.67 K

2. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer

Volume 20, Issue 8, August 2019, Pages 2405-2407

Yuhui Wang; Zhenming Wang; Yansheng Ding; Fengqiang Sun; Xiaomei Ding

• View Article
• PDF 298.07 K

3. Clinical Utility of Haptoglobin in Combination with CEA, NSE and CYFRA21-1 for Diagnosis of Lung Cancer

Volume 15, Issue 22, December 2014, Pages 9611-9614

• View Article
• PDF 555.86 K

4. Preliminary Evaluation of Clinical Utility of CYFRA 21-1, CA 72-4, NSE, CA19-9 and CEA in Stomach Cancer

Volume 15, Issue 12, December 2014, Pages 4933-4938

• View Article
• PDF 431.05 K

5. Clinical Observations on the Association Between Diagnosis of Lung Cancer and Serum Tumor Markers in Combination

Volume 14, Issue 7, July 2013, Pages 4369-4371

• View Article
• PDF 343.52 K

6. For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?

Volume 14, Issue 4, April 2013, Pages 2541-2544

• View Article
• PDF 483.13 K